Skip to content

HCA Healthcare's profits soar 30%, stock jumps 8% on strong outlook

A $10B buyback and dividend hike just sweetened the deal. With revenue targets hitting $80B, HCA's bullish forecast has Wall Street buzzing.

The image shows a graph depicting the increased BAA issuance across industry groups. The graph is...
The image shows a graph depicting the increased BAA issuance across industry groups. The graph is accompanied by text that provides further information about the data.

HCA Healthcare's profits soar 30%, stock jumps 8% on strong outlook

HCA Healthcare has reported robust financial performance for the latest quarter. The company's profit surged to $1.88 billion, or $8.14 per share, up from $1.44 billion, or $5.63 per share, a year earlier. Investors reacted positively, driving the stock price up by 7.86% to $509.52 per share following the announcement.

The company's adjusted earnings came in at $8.01 per share, surpassing analyst expectations of $7.46. This follows a year of remarkable growth, with HCA Healthcare's stock climbing 58% on the stock market over the past twelve months.

Looking ahead, HCA Healthcare has set ambitious targets for 2026. Full-year revenue is projected to reach between $76.5 billion and $80 billion. Net income is expected to fall within the range of $6.495 billion to $7.035 billion, while earnings per share are forecasted to be between $29.10 and $31.50. In addition to strong financial results, the company announced plans to return value to shareholders. The board approved a new $10 billion share buyback program. CEO Sam Hazen also confirmed a six-cent increase in the quarterly dividend, raising it to $0.78 per share.

The latest results underscore HCA Healthcare's continued growth and financial strength. With higher dividends, a new buyback program, and optimistic forecasts for 2026, the company appears well-positioned for the future. Shareholders have already seen a significant boost in stock value following the announcement.

Read also:

Latest